HiberCell
New York
About HiberCell
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $158.2M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (May 2021)
- Website: hibercell.com
- Phone: 212-601-2800
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/hibercell-55777 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.